Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 58,273 | 73,340 | 65,796 | 46,069 | 55,191 |
| Cost of Goods | 30,078 | 35,574 | 36,925 | 25,489 | 35,131 |
| Gross Profit | 28,195 | 37,766 | 28,871 | 20,580 | 20,060 |
| Operating Expenses | 42,829 | 33,745 | 28,855 | 22,815 | 31,757 |
| Operating Income | -14,634 | 4,021 | 16 | -2,235 | -11,697 |
| Interest Expense | 1,331 | 959 | 668 | 660 | 328 |
| Other Income | 1,541 | -12,950 | 27,227 | 7,322 | 22,876 |
| Pre-tax Income | -14,424 | -9,888 | 26,575 | 4,427 | 10,851 |
| Income Tax | -6,123 | -1,302 | -2,429 | 869 | 2,618 |
| Net Income Continuous | -8,301 | -8,586 | 29,004 | 3,558 | 8,233 |
| Net Income | $-8,301 | $-8,586 | $29,004 | $3,558 | $8,233 |
| EPS Basic Total Ops | -0.06 | -0.07 | 0.23 | 0.03 | 0.06 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | 0.23 | 0.03 | 0.06 |
| EPS Diluted Total Ops | -0.06 | -0.07 | 0.23 | 0.03 | 0.06 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | 0.23 | 0.03 | 0.06 |
| EBITDA(a) | $5,908 | $4,066 | $36,273 | $11,795 | $20,792 |